INHA and tuberculosis: Moreover, the phenomenon of cross-resistance (e.g., to both the first-line drug INH and the second-line drug ethionamide due to a missense mutation in the inhA promoter) [49, 50] renders both antibiotics ineffective (ethionamide is a component of the drug regimen for both MDR and XDR TB patients in Ethiopia [1, 22]).